{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T23:06:20Z","timestamp":1786403180299,"version":"build-2736575974"},"reference-count":50,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2024-00450988"],"award-info":[{"award-number":["RS-2024-00450988"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jbc.2025.110675","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T06:34:04Z","timestamp":1756794844000},"page":"110675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Ubiquitin-specific protease 7 promotes the growth and oncogenic potential of acute myeloid leukemia cells through the deubiquitination and upregulation of LRRK2"],"prefix":"10.1016","volume":"301","author":[{"given":"Joon Hyung","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4658-3849","authenticated-orcid":false,"given":"Kwang Chul","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2025.110675_bib1","doi-asserted-by":"crossref","first-page":"eadl3438","DOI":"10.1126\/scitranslmed.adl3438","article-title":"LRRK2 regulates production of reactive oxygen species in cell and animal models of Parkinson's disease","volume":"16","author":"Keeney","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jbc.2025.110675_bib2","first-page":"1","article-title":"Leucine-rich repeat kinase 2 exacerbates neuronal cytotoxicity through phosphorylation of histone deacetylase 3 and histone deacetylation","volume":"26","author":"Han","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jbc.2025.110675_bib3","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nn.3350","article-title":"Interplay of LRRK2 with chaperone-mediated autophagy","volume":"16","author":"Orenstein","year":"2013","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.jbc.2025.110675_bib4","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1073\/pnas.0810123106","article-title":"CHIP regulates leucine-rich repeat kinase-2 ubiquitination, degradation, and toxicity","volume":"106","author":"Ko","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2025.110675_bib5","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202010065","article-title":"The E3 ligase TRIM1 ubiquitinates LRRK2 and controls its localization, degradation, and toxicity","volume":"221","author":"Stormo","year":"2022","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jbc.2025.110675_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-021-02047-y","article-title":"LRRK2 is a candidate prognostic biomarker for clear cell renal cell carcinoma","volume":"21","author":"Yang","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.jbc.2025.110675_bib7","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.1038\/s41388-022-02499-0","article-title":"Distinct molecular subtypes of papillary thyroid carcinoma and gene signature with diagnostic capability","volume":"41","author":"Hong","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.jbc.2025.110675_bib8","doi-asserted-by":"crossref","first-page":"319","DOI":"10.15283\/ijsc24032","article-title":"Suppression of glioblastoma stem cell potency and tumor growth via LRRK2 inhibition","volume":"17","author":"Park","year":"2024","journal-title":"Int. J. Stem Cells"},{"key":"10.1016\/j.jbc.2025.110675_bib9","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s10620-019-05806-0","article-title":"LRRK2 is associated with recurrence-free survival in intrahepatic cholangiocarcinoma and downregulation of LRRK2 suppresses tumor progress in vitro","volume":"65","author":"Gu","year":"2020","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.jbc.2025.110675_bib10","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3164\/jcbn.22-122","article-title":"Knockdown of LRRK2 inhibits the progression of lung cancer by regulating TLR4\/NF-\u03baB pathways and NLRP3 inflammasome","volume":"73","author":"Wu","year":"2023","journal-title":"J. Clin. Biochem. Nutr."},{"key":"10.1016\/j.jbc.2025.110675_bib11","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1016\/j.ymthe.2023.07.021","article-title":"Targeting leucine-rich repeat serine\/threonine-protein kinase 2 sensitizes pancreatic ductal adenocarcinoma to anti-PD-L1 immunotherapy","volume":"31","author":"Sun","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jbc.2025.110675_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2023.188992","article-title":"Current and future directions of USP7 interactome in cancer study","volume":"1878","author":"Park","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.jbc.2025.110675_bib13","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nsmb1067","article-title":"Molecular recognition of p53 and MDM2 by USP7\/HAUSP","volume":"13","author":"Sheng","year":"2006","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.jbc.2025.110675_bib14","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201744766","article-title":"USP7 and USP47 deubiquitinases regulate NLRP3 inflammasome activation","volume":"19","author":"Palaz\u00f3n-Riquelme","year":"2018","journal-title":"EMBO Rep."},{"key":"10.1016\/j.jbc.2025.110675_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2022.110351","article-title":"USP7 inhibits TIMP2 by up-regulating the expression of EZH2 to activate the NF-\u03baB\/PD-L1 axis to promote the development of cervical cancer","volume":"96","author":"Li","year":"2022","journal-title":"Cell Signal."},{"key":"10.1016\/j.jbc.2025.110675_bib16","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature737","article-title":"Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization","volume":"416","author":"Li","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.jbc.2025.110675_bib17","doi-asserted-by":"crossref","first-page":"5649","DOI":"10.1093\/hmg\/ddu281","article-title":"Genetic dissection reveals that Akt is the critical kinase downstream of LRRK2 to phosphorylate and inhibit FOXO1, and promotes neuron survival","volume":"23","author":"Chuang","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jbc.2025.110675_bib18","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1210\/me.2013-1420","article-title":"USP7 attenuates hepatic gluconeogenesis through modulation of FoxO1 gene promoter occupancy","volume":"28","author":"Hall","year":"2014","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jbc.2025.110675_bib19","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1093\/hmg\/ddq289","article-title":"Activation of FoxO by LRRK2 induces expression of proapoptotic proteins and alters survival of postmitotic dopaminergic neuron in Drosophila","volume":"19","author":"Kanao","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jbc.2025.110675_bib20","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/ncb1469","article-title":"FOXO4 transcriptional activity is regulated by monoubiquitination and USP7\/HAUSP","volume":"8","author":"van der Horst","year":"2006","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jbc.2025.110675_bib21","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41418-020-00703-w","article-title":"The ubiquitin system: from cell signalling to disease biology and new therapeutic opportunities","volume":"28","author":"Damgaard","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jbc.2025.110675_bib22","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ccr.2012.08.007","article-title":"A small molecule inhibitor of ubiquitin-specific protease-7 induces apoptosis in multiple myeloma cells and overcomes bortezomib resistance","volume":"22","author":"Chauhan","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jbc.2025.110675_bib23","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.chembiol.2012.02.007","article-title":"Discovery of specific inhibitors of human USP7\/HAUSP deubiquitinating enzyme","volume":"19","author":"Reverdy","year":"2012","journal-title":"Chem. Biol."},{"key":"10.1016\/j.jbc.2025.110675_bib24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.21037\/tcr-23-1228","article-title":"A pancancer analysis of histone deacetylase 3 in human tumors","volume":"13","author":"Chen","year":"2024","journal-title":"Transl Cancer Res."},{"key":"10.1016\/j.jbc.2025.110675_bib25","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.pan.2019.01.011","article-title":"HDAC3 modulates cancer immunity via increasing PD-L1 expression in pancreatic cancer","volume":"19","author":"Hu","year":"2019","journal-title":"Pancreatology"},{"key":"10.1016\/j.jbc.2025.110675_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-020-1536-x","article-title":"Enhanced histone H3 acetylation of the PD-L1 promoter via the COP1\/c-Jun\/HDAC3 axis is required for PD-L1 expression in drug-resistant cancer cells","volume":"39","author":"Wang","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jbc.2025.110675_bib27","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1158\/1535-7163.MCT-18-1068","article-title":"HDAC3 inhibition upregulates PD-L1 expression in B-cell lymphomas and augments the efficacy of anti\u2013PD-L1 therapy","volume":"18","author":"Deng","year":"2019","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jbc.2025.110675_bib28","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3390\/cells13070565","article-title":"LRRK2 G2019S promotes Colon cancer potentially via LRRK2-GSDMD axis-mediated gut inflammation","volume":"13","author":"Wang","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.jbc.2025.110675_bib29","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/mds.25969","article-title":"LRRK2-G2019S mutation is not associated with an increased cancer risk: a kin-cohort study","volume":"29","author":"Allegra","year":"2014","journal-title":"Mov Disord."},{"key":"10.1016\/j.jbc.2025.110675_bib30","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.3233\/JPD-230432","article-title":"How parkinson's disease-linked LRRK2 mutations affect different CNS cell types","volume":"14","author":"Bailey","year":"2024","journal-title":"J. Parkinson\u2019s Dis."},{"key":"10.1016\/j.jbc.2025.110675_bib31","first-page":"21","article-title":"Downregulated LRRK2 gene expression inhibits proliferation and migration while promoting the apoptosis of thyroid cancer cells by inhibiting activation of the JNK signaling pathway","volume":"55","author":"Jiang","year":"2019","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.jbc.2025.110675_bib32","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra1406184","article-title":"Acute myeloid leukemia","volume":"373","author":"D\u00f6hner","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbc.2025.110675_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117788","article-title":"Targeting FMS-like tyrosine kinase 3 (FLT3) in acute myeloid leukemia: novel molecular approaches and therapeutic challenges","volume":"182","author":"Rataj","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jbc.2025.110675_bib34","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1182\/blood-2013-01-479188","article-title":"Clonal evolution in relapsed NPM1-mutated acute myeloid leukemia","volume":"122","author":"Kr\u00f6nke","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2025.110675_bib35","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.1234769","article-title":"Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation","volume":"340","author":"Wang","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jbc.2025.110675_bib36","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/nchembio.2486","article-title":"Inhibition of USP10 induces degradation of oncogenic FLT3","volume":"13","author":"Weisberg","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.jbc.2025.110675_bib37","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/s41375-021-01394-z","article-title":"The deubiquitinase USP15 modulates cellular redox and is a therapeutic target in acute myeloid leukemia","volume":"36","author":"Niederkorn","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.jbc.2025.110675_bib38","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.16348","article-title":"Therapeutic inhibition of USP7-PTEN network in chronic lymphocytic leukemia: a strategy to overcome TP53 mutated\/deleted clones","volume":"8","author":"Carr\u00e0","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jbc.2025.110675_bib39","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1172\/JCI85747","article-title":"Stabilization of histone demethylase PHF8 by USP7 promotes breast carcinogenesis","volume":"126","author":"Wang","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jbc.2025.110675_bib40","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1007\/s13277-014-2773-4","article-title":"USP7 overexpression predicts a poor prognosis in lung squamous cell carcinoma and large cell carcinoma","volume":"36","author":"Zhao","year":"2015","journal-title":"Tumor Biol."},{"key":"10.1016\/j.jbc.2025.110675_bib41","first-page":"1559","article-title":"Ubiquitin-specific protease 7 expression is a prognostic factor in epithelial ovarian cancer and correlates with lymph node metastasis","volume":"9","author":"Ma","year":"2016","journal-title":"Oncotargets Ther."},{"key":"10.1016\/j.jbc.2025.110675_bib42","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.expneurol.2014.05.025","article-title":"LRRK2, a puzzling protein: insights into Parkinson's disease pathogenesis","volume":"261","author":"Esteves","year":"2014","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jbc.2025.110675_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-019-0344-2","article-title":"LRRK2 Biology from structure to dysfunction: research progresses, but the themes remain the same","volume":"14","author":"Berwick","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.jbc.2025.110675_bib44","doi-asserted-by":"crossref","first-page":"5827","DOI":"10.1038\/ncomms6827","article-title":"Phosphorylation of LRRK2 by casein kinase 1\u03b1 regulates trans-Golgi clustering via differential interaction with ARHGEF7","volume":"5","author":"Chia","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2025.110675_bib45","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1042\/BJ20121772","article-title":"Identification of protein phosphatase 1 as a regulator of the LRRK2 phosphorylation cycle","volume":"456","author":"Lobbestael","year":"2013","journal-title":"Biochem. J."},{"key":"10.1016\/j.jbc.2025.110675_bib46","article-title":"USP7 Promotes deubiquitination and stabilization of MyD88 to enhance immune responses","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jbc.2025.110675_bib47","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.add3243","article-title":"HDAC3 is critical in tumor development and therapeutic resistance in Kras-mutant non-small cell lung cancer","volume":"9","author":"Eichner","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jbc.2025.110675_bib48","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13148-018-0589-6","article-title":"HDAC is indispensable for IFN-\u03b3-induced B7-H1 expression in gastric cancer","volume":"10","author":"Deng","year":"2018","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.jbc.2025.110675_bib49","doi-asserted-by":"crossref","first-page":"7277","DOI":"10.1158\/0008-5472.CAN-16-2100","article-title":"CBX4 suppresses metastasis via recruitment of HDAC3 to the Runx2 promoter in colorectal carcinoma","volume":"76","author":"Wang","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.jbc.2025.110675_bib50","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/mds.25778","article-title":"Prevalence of cancer in Parkinson's disease related to R1441G and G2019S mutations in LRRK2","volume":"29","author":"Ruiz-Mart\u00ednez","year":"2014","journal-title":"Mov Disord."}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002192582502527X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002192582502527X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T08:48:53Z","timestamp":1773132533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002192582502527X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S002192582502527X"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2025.110675","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ubiquitin-specific protease 7 promotes the growth and oncogenic potential of acute myeloid leukemia cells through the deubiquitination and upregulation of LRRK2","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2025.110675","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology\u00e9","name":"copyright","label":"Copyright"}],"article-number":"110675"}}